Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation

Journal of Molecular Biology

Volumn 294, Issue 2, 1999, Pages 403-416

  Dias, Nathalie ^a   Dheur, Sonia ^a   Nielsen, Peter E ^b   Gryaznov, Sergei ^c   Van Aerschot, Arthur ^d   Herdewijn, Piet ^d   Hélène, Claude ^a   Saison Behmoaras, Tula E ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GERON CORPORATION   (United States)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Affinity of interaction; Antisense; Ha ras mRNA; PNA RNA duplexes; Translation elongation arrest

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DOUBLE STRANDED DNA; MESSENGER RNA; MUTANT PROTEIN; PEPTIDE NUCLEIC ACID; PHOSPHORAMIDIC ACID DERIVATIVE; POLYPEPTIDE; SUGAR NUCLEOTIDE;

ARTICLE; BASE PAIRING; CODON; CONTROLLED STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RABBIT; RIBOSOME; RNA HYBRIDIZATION; RNA SEQUENCE; TRANSLATION REGULATION;

ORYCTOLAGUS CUNICULUS;

EID: 0033607615     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3277     Document Type: Article

References (44)

1. Aldrian-Herrada G., Desarménien M. G., Orcel H., Boissin-Agasse L., Méry J., Brugidou J., Rabié A. A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucl. Acids Res. 26:1998;4910-4916.
2. Baker B. F., Lot S. S., Condon T. P., Cheng-Flournoy S., Lesnik E. A., Sasmor H. M., Benett F. 2′-O-(2-Methoxy)-ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272:1997;11994-12000.
3. Barabino S. M., Sproat B. S., Lamond A. I. Antisense probes targeted to an internal domain in U2 snRNP specifically inhibit the second step of pre-mRNA splicing. Nucl. Acids Res. 20:1992;4457-4464.
4. Bonham M. A., Brown S., Boyd A. L., Brown P. H., Bruckenstein D. A., Hanvey J. C., Thomson S. A., Pipe A., Hassman F., Bisi J. E., Froehler B. C., Matteucci M. D., Wagner R. W., Noble S. A., Babiss L. E. An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucl. Acids Res. 23:1995;1197-1203.
5. Boudvillain M., Guérin M., Dalbiès R., Saison-Behmoaras T., Leng M. Transplatin-modified oligo (2′-O-methyl ribonucleotide)s: a new tool for selective modulation of gene expression. Biochemistry. 36:1997;2925-2931.
6. Brown D. A., Kang S. H., Gryaznov S. M., DeDionisio L., Heidenreich O., Sullivan S., Xu X., Nerenberg M. I. Effect of phosphorothioate modification of oligonucleotides on specific protein binding. J. Biol. Chem. 269:1994;26801-26805.
7. Burgess T. L., Fisher E. F., Ross S. L., Bready J. V., Qian Y-X., Bayewitch L. A., Cohen A. M., Herrera C. J., Hu S. S-F., Kramer T. B., Lott F. D., Martin F. H., Pierce G. F., Simonet L., Farell C. L. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl Acad. Sci. USA. 92:1995;4051-4055.
8. Chen J.-K., Schultz R. G., Lloyd D. A., Gryaznov S. M. Synthesis of oligodeoxyribonucleotide N3′→P5′ phosphoramidates. Nucl. Acids Res. 23:1995;2661-2668.
9. Chiang M.-Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Benett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266:1991;18162-18167.
10. Christensen L., Fitzpatrick R., Gildea B., Petersen K. H., Hansen H. F., Koch T., Egholm M., Buchardt O., Nielsen P. E., Coull J., Berg R. H. Solid-phase synthesis of peptide nucleic acids. J. Pept. Sci. 3:1995;175-183.
11. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids. Res. 11:1983;1475-1489.
12. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:1996;18188-18193.
13. Duroux I., Godard G., Boidot-Forget M., Schwab G., Hélène C., Saison-Behmoaras T. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells. Nucl. Acids Res. 23:1995;3411-3418.
14. Egholm M., Buchardt O., Christensen L., Behrens C., Freier S. M., Driver D. A., Berg R. H., Kim S. K., Norden B., Nielsen P. E. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature. 365:1993;566-568.
15. Gambacorti-Passerini C., Mologni I., Bertazzoli C., Le Coutre P., Marchesi E., Grignani F., Nielsen P. E. In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid. Blood. 88:1996;1411-1417.
16. Gee J. E., Robbins I., Van Der Laan A. C., Van Boom J. H., Colombier C., Leng M., Raible A. M., Nelson J. S., Lebleu B. Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides. Antisense Nucl. Acid Drug Dev. 8:1998;103-111.
17. Good L., Nielsen P. E. Progress in developing PNA as a gene-targeted drug. Antisense Nucl. Acid Drug Dev. 7:1997;431-437.
18. Gryaznov S., Chen J.-K. Oligodeoxyribonucleotide N3′→P5′ phosphoramidates: synthesis and hybridization properties. J. Am. Chem. Soc. 116:1994;3143-3144.
19. Gryaznov S., Skorski T., Cucco C., Nieborowska-Skorska M., Chiu C. Y., Lloyd D., Chen J.-K., Koziolkiewicz M., Calabretta B. Oligonucleotide N3′→P5′ phosphoramidates as antisense agents. Nucl. Acids Res. 24:1996;1508-1514.
20. Guvakova M. A., Yakubov L. A., Vlodavski I., Tonkinson J. L., Stein C. A. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J. Biol. Chem. 270:1995;2620-2627.
21. Hanvey J. C., Peffer N. J., Bisi J. E., Thomson S. A., Cadilla A. R., Josey J. A., Ricca D. J., Hassman C. F., Bonham M. A., Au K. G., Carter S. G., Bruckenstein D. A., Boyd A. L., Noble S. A., Babiss L. E. Antisense and antigene properties of peptide nucleic acids. Science. 258:1992;1481-1485.
22. Hélène C., Toulmé J. J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta. 1049:1990;99-125.
23. Igloi G. L. Variability in the stability of DNA-peptide nucleic acid (PNA) single-base mismatched duplexes: real-time hybridization during affinity electrophoresis in PNA containing gels. Proc. Natl Acad. Sci. USA. 95:1998;8562-8567.
24. Jensen K. K., Orum H., Nielsen P. E., Norden B. Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique. Biochemistry. 36:1997;5072-5077.
25. Johansson H. E., Belsham G. J., Sproat B. S., Hentze M. W. Target-specific arrest of mRNA translation by antisense 2′-O-alkyloligoribonucleotides. Nucl. Acids Res. 22:1994;4591-4598.
26. Knudsen H., Nielsen P. E. Antisense properties of duplex- and triplex-forming PNAs. Nucl. Acids Res. 24:1996;494-500.
27. Koppelhus U., Zachar V., Nielsen P. E., Liu X., Eugen-Olsen J., Ebbesen P. Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA. Nucl. Acids Res. 25:1997;2167-2173.
28. Kozak M. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell Biol. 9:1989;5134-5142.
29. Krieg A. M., Yi A-K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., Koretzky G. A., Klinman D. M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
30. Liebhaber S. A., Cash F., Eshleman S. S. Translation inhibition by an mRNA coding region secondary structure is determined by its proximity to the AUG initiation codon. J. Mol. Biol. 226:1992;609-621.
31. Maher J., Dolnick B. J. Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell free system. Nucl. Acids Res. 16:1988;3341-3358.
32. Melton D. A. Injected anti-sense RNAs specifically block messenger RNA translation in vivo. Proc. Natl Acad. Sci. USA. 82:1985;144-148.
33. Miller P. S. Development of antisense and antigene oligonucleotide analogs. Prog. Nucl. Acids Res. Mol. Biol. 52:1996;261-291.
34. Monia B. P., Johnston J. F., Ecker D. J., Zounes M. A., Lima W. F., Freier S. M. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267:1992;19954-19962.
35. Monia B. P., Lesnik E. A., Gonzalez C., Lima W. F., McGee D., Guinosso C. J., Kawasaki A. M., Cook P. D., Freir S. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268:1993;14514-14522.
36. Monia B. P., Johnston J. F., Sasmor H., Cummins L. L. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J. Biol. Chem. 271:1996;14533-14540.
37. Pantopoulos K., Johansson H. E., Hentze M. W. The role of the 5′ untranslated region of eucaryotic messenger RNAs in translation and its investigation using antisense technologies. Prog. Nucl. Acids Res. Mol. Biol. 48:1994;181-238.
38. Pooga M., Soomets U., Hällbrink M., Valkna A., Külliki S., Rezaei K., Kahl U., Hao J.-X., Xu X.-J., Wiesenfeld-Hallin Z., Hökfelt T., Bartfai T., Langel Ü. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain trasmission in vivo. Nature Biotechnol. 16:1998;857-861.
39. Saison-Behmoaras T., Tocqué B., Rey I., Chassignol M., Thuong N. T., Hélène C. Short modified antisense oligonucleotides directed against Ha-ras point mutation induced selective cleavage of the mRNA and inhibit T24 cells proliferation. EMBO J. 10:1991;1111-1118.
40. Schwab G., Chavany C., Duroux I., Goubin G., Lebeau J., Hélène C., Saison-Behmoaras T. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated proliferation and tumorigenicity in nude mice. Proc. Natl Acad. Sci. USA. 91:1994;10460-10464.
41. Stein C. A. Does antisense exist? Nature Med. 1:1995;1119-1121.
42. Tyler B. M., Jansen K., McCormick D. J., Douglas C. L., Boules M., Stewart J. A., Zhao L., Lacy B., Cusack B., Fauq A. Peptide nucleic acids targeted to the neurotensin receptor and administrated i. p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl Acad. Sci. USA. 96:1999;7053-7058.
43. Uhlmann E., Peyman A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90:1990;543-583.
44. Woolf T. D. To cleave or not to cleave: ribozymes and antisense. Antisense Res. Dev. 5:1995;227-232.